Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
9464322
Publication Date
10-11-2016
Abstract
The subject technology relates, in part, to a method of treating Alzheimer's Disease (AD), early-stage AD, elevated risk of AD, mild cognitive impairment (MCI), or other forms of age-related cognitive decline in a subject in need thereof by administering to the subject a molecule that promotes calcium-release stabilization in ryanodine receptors (RyRs) and/or inosital triphosphate receptors (InsP3Rs) in brain cells. Diagnostic methods using calcium-release stabilizing immunophilins, junctophilins or calmodulin are also disclosed.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
13/608,596
Filing Date
09/10/2012
Recommended Citation
Landfield, Philip W.; Gant, John C.; Blalock, Eric M.; Chen, Kuey-Chu; Thibault, Olivier; and Porter, Nada M., "Methods for Diagnosing and Treating Alzheimer's Disease (AD) Using the Molecules that Stabilize Intracellular Calcium (CA2+) Release" (2016). Pharmacology and Nutritional Sciences Faculty Patents. 50.
https://uknowledge.uky.edu/pharmacol_patents/50
